Table 3.
Immunogen | Adjuvant | Animal model |
Immunization route |
Results | Refs. |
---|---|---|---|---|---|
P. gingivalis hemoglobin- binding domain of gingipain (HA2) |
Freund’s complete adjuvant |
rats | subcutaneous | High levels of serum IgG antibody responses Protection against bone loss * |
(44) |
Purified ariginine gingipains (RgpA or RgpB) from P. gingivalis |
Freund’s complete adjuvant |
mice | subcutaneous | Elevated IgG antibody responses Protection against bone loss in animals immunized with RgpA but not with RgpB |
(67) |
Proteinase adhesin complex ( RgpA- Kgp) from P. gingivalis |
Freund’s incomplete adjuvant |
rats | subcutaneous | High-titer serum IgG2a antibody responses Protection against bone loss Inhibition of P. gingivalis colonization |
(184) |
P. gingivalis cysteine proteinase (porphypain-2) |
Freund’s incomplete adjuvant |
monkeys | intramuscular & subcutaneous |
Elevated IgG antibody responses Reduction in total number of gram-negative anaerobes but not of P. gingivalis |
(159) |
P. gingivalis recombinant hemagglutinin B |
monophosphoryl lipid A | mice | intranasal | High levels of serum IgG and salivary IgA antibody responses |
(245) |
Fimbrial peptide from A. actinomycetemcomi tans |
Ribi adjuvant system R-700 ** |
mice | intramuscular | High-titer serum IgG antibody responses In vitro inhibition of A. actinomycetem- comitans adherence by anti-peptide serum IgG antibodies |
(101) |
Fimbrial peptide from A. actinomycetemcomi tans |
cholera toxin and IL-4- expressing plasmid |
mice | intranasal | High levels of salivary IgA antibody responses |
(101) |
Formalin-killed P. gingivalis |
Syntex Adjuvant Formulation-M *** |
monkeys | intramuscular & subcutaneous |
Elevated serum IgG antibody responses Protection against bone loss Modest inhibitory effect against P. gingivalis colonization |
(178) |
Formalin-killed P. gingivalis |
Syntex Adjuvant Formulation-M *** |
monkeys | intramuscular & subcutaneous |
Elevated IgG antibody responses in gingival crevicular fluid Suppressed gingival crevicular fluid levels of prostaglandin E2 Inhibition of bone loss |
(187) |
The adjuvant was associated with enhanced IgG responses (vs. immunogen alone) but not with bone loss protection
Emulsion of monophosphoryl lipid A and synthetic trehalose dicorynomycolate
Oil-in-water emulsion stabilized by Tween 80 and pluronic polyoxyethlene/polyoxypropylene block copolymer L121(Syntex Laboratories, Palo Alto, CA)